These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. Kohlhoff SA; Huband MD; Hammerschlag MR Antimicrob Agents Chemother; 2014 Dec; 58(12):7595-6. PubMed ID: 25288086 [TBL] [Abstract][Full Text] [Related]
8. Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion. Ur-Rehman T; Slepenkin A; Chu H; Blomgren A; Dahlgren MK; Zetterström CE; Peterson EM; Elofsson M; Gylfe A J Antibiot (Tokyo); 2012 Aug; 65(8):397-404. PubMed ID: 22669447 [TBL] [Abstract][Full Text] [Related]
9. The endogenous antiseptic N-chlorotaurine irreversibly inactivates Chlamydia pneumoniae and Chlamydia trachomatis. Bellmann-Weiler R; Maass V; Arnitz R; Weiss G; Maass M; Nagl M J Med Microbiol; 2018 Sep; 67(9):1410-1415. PubMed ID: 30074473 [TBL] [Abstract][Full Text] [Related]
10. Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia. Rahman MA; Azuma Y; Fukunaga H; Murakami T; Sugi K; Fukushi H; Miura K; Suzuki H; Shirai M J Antimicrob Chemother; 2005 Nov; 56(5):861-8. PubMed ID: 16172105 [TBL] [Abstract][Full Text] [Related]
11. Characterization of in vitro chlamydial cultures in low-oxygen atmospheres. Juul N; Jensen H; Hvid M; Christiansen G; Birkelund S J Bacteriol; 2007 Sep; 189(18):6723-6. PubMed ID: 17631631 [TBL] [Abstract][Full Text] [Related]
12. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Peterson TG; Coward L; Kirk M; Falany CN; Barnes S Carcinogenesis; 1996 Sep; 17(9):1861-9. PubMed ID: 8824507 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and therapy of Chlamydia pneumoniae and trachomatis]. Freidank H Internist (Berl); 1997 Oct; 38(10):995-6. PubMed ID: 9432510 [No Abstract] [Full Text] [Related]
14. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation. Han HK; Lee BJ; Lee HK Int J Pharm; 2011 Aug; 415(1-2):89-94. PubMed ID: 21645596 [TBL] [Abstract][Full Text] [Related]
16. Potential for antimicrobial resistance in Chlamydia pneumoniae. Stamm WE J Infect Dis; 2000 Jun; 181 Suppl 3():S456-9. PubMed ID: 10839739 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. Alvesalo J; Vuorela H; Tammela P; Leinonen M; Saikku P; Vuorela P Biochem Pharmacol; 2006 Mar; 71(6):735-41. PubMed ID: 16414027 [TBL] [Abstract][Full Text] [Related]
18. Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. Al-Younes HM; Gussmann J; Braun PR; Brinkmann V; Meyer TF J Med Microbiol; 2006 Jul; 55(Pt 7):879-886. PubMed ID: 16772415 [TBL] [Abstract][Full Text] [Related]
19. [Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae]. Zele-Starcević L; Plecko V; Budimir A; Kalenić S Acta Med Croatica; 2004; 58(4):329-33. PubMed ID: 15700690 [TBL] [Abstract][Full Text] [Related]
20. Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis. Hao H; Aixia Y; Dan L; Lei F; Nancai Y; Wen S Fitoterapia; 2009 Oct; 80(7):448-52. PubMed ID: 19524644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]